The technology, developed by Israeli firm PixCell Medical, provides lab-quality complete blood count testing from a single drop of blood. By moving diagnostics directly to the point of care, clinical teams at organizations including the South London and Maudsley NHS Foundation Trust and the Oxford University Hospitals NHS Foundation Trust are reducing the reliance on external lab transport and complex nursing logistics.
PixCell Medical Scales Rapid Deployment of HemoScreen Across NHS Trusts
More than one-third of NHS mental health trusts have adopted the HemoScreen blood analyzer, marking a significant shift toward decentralized diagnostics. Originally piloted for clozapine monitoring, the device now supports routine hematology across community clinics and secure psychiatric units to bypass traditional laboratory workflows.
This shift addresses specific barriers in psychiatric care, particularly for patients struggling with needle phobia or severe anxiety. Dr. Avishay Bransky, CEO of PixCell Medical, noted that the primary value lies in removing these obstacles to treatment adherence. Clinical feedback from the Kent and Medway NHS and Social Care Partnership Trust highlights that the finger-stick method has proven essential in keeping patients engaged with their treatment plans, ultimately enabling faster clinical decisions in sensitive care environments.
Comments (0)
No comments yet. Be the first!